9 studies found for:    Immunovative
Show Display Options
Rank Status Study
1 Not yet recruiting Study of AlloStim In-Situ Vaccine in Pre-Treated Metastatic Breast Cancer
Condition: Metastatic Breast Cancer
Interventions: Biological: AlloStim;   Procedure: cryoablation
2 Not yet recruiting Increased Frequency of AlloStim(TM) Dosing in Combination With Cryoablation in Metastatic Breast Cancer Patients
Condition: Metastatic Breast Cancer
Interventions: Biological: AlloStim;   Procedure: Cryoablation
3 Not yet recruiting Safety and Tolerability Study of AlloVax(TM) in Patients With Metastatic or Recurrent Cancer of the Head and Neck
Conditions: Cancer of Head and Neck;   Squamous Cell Carcinoma of the Head and Neck
Interventions: Biological: AlloVax;   Biological: CRCL;   Biological: AlloStim
4 Completed In-Situ Therapeutic Cancer Vaccine for Metastatic Cancer Combining AlloStim With Tumor Cryoablation
Condition: Metastatic Cancer
Interventions: Biological: AlloStim-7;   Procedure: percutaneous tumor cryoablation;   Biological: AlloStim8 or AlloStim-9
5 Terminated Study of Bioengineered Allogeneic Immune Cells (AlloStim) Not Requiring HLA Donor Match Alternative to Allogeneic Transplant for Blood Cancers
Condition: Advanced or Refractory Leukemia, Lymphoma, Multiple Myeloma
Intervention: Biological: AlloStim-8
6 Active, not recruiting A Phase I/II Study of Mis-Matched Immune Cells (AlloStim) in Patients With Advanced Hematological Malignancy
Conditions: Hematological Malignancy;   Leukemia;   Lymphoma;   Multiple Myeloma
Intervention: Biological: AlloStim
7 Withdrawn Experimental Therapeutic Cancer Vaccine Created In-situ in Patients With Stage II-Stage IV Cancer
Conditions: Solid Tumors Stage II, Stage III and Stage IV;   Breast Cancer;   Colorectal Cancer;   Prostate Cancer;   Melanoma;   Ovarian Cancer;   Sarcoma;   Non-small Cell Lung Cancer
Interventions: Biological: AlloStim;   Procedure: Cryoablation
8 Not yet recruiting An Individualized Anti-Cancer Vaccine Study in Patients With HCC
Condition: Hepatocellular Carcinoma
Interventions: Biological: AlloVax;   Biological: CRCL;   Biological: AlloStim
9 Not yet recruiting In-Situ Therapeutic Cancer Vaccine for Refractory Liver Cancer
Condition: Hepatocellular Carcinoma
Intervention: Biological: AlloStim

Indicates status has not been verified in more than two years